LNWWM
GBIO

Laird Norton Wetherby Wealth Management’s Generation Bio GBIO Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-759
Closed -$204K – 939
2021
Q2 		$204K Buy
+759
New +$227K 0.01% 866

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's GBIO Position: Q3 2021 in Review

Laird Norton Wetherby Wealth Management sold out of Generation Bio (GBIO) in Q3 2021, closing a stake of 759 shares — an estimated $204K sold.

Laird Norton Wetherby Wealth Management first reported a position in GBIO in Q2 2021 and held it in 1 quarter. The position peaked at $204K in Q2 2021. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Laird Norton Wetherby Wealth Management reported no remaining Generation Bio position as of Q3 2021 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 759 Generation Bio shares in Q3 2021, an estimated $204K.
  • Laird Norton Wetherby Wealth Management first reported a position in Generation Bio in Q2 2021 and held it in 1 quarter.
  • Laird Norton Wetherby Wealth Management's Generation Bio position peaked at $204K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.